Cilta-Cel is Associated with Improved Outcomes and Distinct Cellular Dynamics Compared with Ide-Cel for Relapsed or Refractory Multiple Myeloma
Nico Gagelmann,Friedrich Stölzel,Roland Fenk,Tobias A.W. Holderried,Fabian Mueller,Natalia Tovar,Aina Oliver-Caldés,Kristin Rathje,Vladan Vucinic,Soraya Kharboutli, Ben-Niklas Bärmann,Francis A. Ayuk,Uwe Platzbecker, Anca Maria Albici,Natalie Schub,Friederike Schmitz,Cyrus Khandanpour,Marcel Teichert,Barbara Jeker,Nicolaus Kroeger,Bastian von Tresckow,Carlos Fernandez de Larrea,Thomas Pabst,Maximilian Merz Blood（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper